Gene therapy

被引：4

作者：

Badiavas, EV ^{[1
]}

Falanga, V ^{[1
]}

机构：

[1] Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Dermatol & Skin Surg, Providence, RI 02908 USA

来源：

JOURNAL OF DERMATOLOGY | 2001年 / 28卷 / 04期

关键词：

gene therapy; gene transfer; transfection; transduction;

D O I：

10.1111/j.1346-8138.2001.tb00116.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

With recent advances in molecular biology, the ability to transfer genes to patients is becoming a reality. Ongoing clinical trials using gene transfer techniques have illustrated the potential and pitfalls of this new therapeutic modality for the treatment of a wide variety of disorders. While these techniques are not currently a part of routine clinical practice, it is only a matter of time until some form of gene therapy is approved for general use in the clinic. This review highlights some of the basic methods used in current gene therapy protocols. The objective of this review is to familiarize practitioners with these concepts so they can more effectively follow the progress of this emerging technology and better inform their patients.

引用

收藏

页码：175 / 192

页数：18

相关论文

共 79 条

[1] Antisense therapeutics: is it as simple as complementary base recognition? [J].

Agrawal, S ;

Kandimalla, ER .

MOLECULAR MEDICINE TODAY, 2000, 6 (02) :72-81

[2] DNA-DAMAGING AGENTS GREATLY INCREASE THE TRANSDUCTION OF NONDIVIDING CELLS BY ADENOASSOCIATED VIRUS VECTORS [J].

ALEXANDER, IE ;

RUSSELL, DW ;

MILLER, AD .

JOURNAL OF VIROLOGY, 1994, 68 (12) :8282-8287

[3] Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide [J].

Alexeev, V ;

Igoucheva, O ;

Domashenko, A ;

Cotsarelis, G ;

Yoon, K .

NATURE BIOTECHNOLOGY, 2000, 18 (01) :43-47

[4] PHENOTYPIC CORRECTION OF FACTOR-IX DEFICIENCY IN SKIN FIBROBLASTS OF HEMOPHILIC DOGS [J].

AXELROD, JH ;

READ, MS ;

BRINKHOUS, KM ;

VERMA, IM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) :5173-5177

[5] Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: A phase I clinical trial [J].

Bellon, G ;

MichelCalemard, L ;

Thouvenot, D ;

Jagneaux, V ;

Poitevin, F ;

Malcus, C ;

Accart, N ;

Layani, MP ;

Aymard, M ;

Bernon, H ;

Bienvenu, J ;

Courtney, M ;

Doring, G ;

Gilly, B ;

Gilly, R ;

Lamy, D ;

Levrey, H ;

Morel, Y ;

Paulin, C ;

Perraud, F ;

Rodillon, L ;

Sene, C ;

So, S ;

TouraineMoulin, F ;

Schatz, C ;

Pavirani, A .

HUMAN GENE THERAPY, 1997, 8 (01) :15-25

[6] TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY DISEASE (SCID) DUE TO ADENOSINE-DEAMINASE DEFICIENCY WITH CD34+ SELECTED AUTOLOGOUS PERIPHERAL-BLOOD CELLS TRANSDUCED WITH A HUMAN ADA GENE [J].

BLAESE, RM .

HUMAN GENE THERAPY, 1993, 4 (04) :521-527

[7] INHIBITION OF MELANOMA GROWTH BY ADENOVIRAL-MEDIATED HSV THYMIDINE KINASE GENE-TRANSFER IN-VIVO [J].

BONNEKOH, B ;

GREENHALGH, DA ;

BUNDMAN, DS ;

ECKHARDT, JN ;

LONGLEY, MA ;

CHEN, SH ;

WOO, SLC ;

ROOP, DR .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (03) :313-317

[8] REGRESSION OF ESTABLISHED MACROSCOPIC LIVER METASTASES AFTER IN-SITU TRANSDUCTION OF A SUICIDE GENE [J].

CARUSO, M ;

PANIS, Y ;

GAGANDEEP, S ;

HOUSSIN, D ;

SALZMANN, JL ;

KLATZMANN, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :7024-7028

[9] Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants [J].

Chan, SY ;

Li, KW ;

Piccotti, JR ;

Louie, MC ;

Judge, TA ;

Turka, LA ;

Eichwald, EJ ;

Bishop, DK .

NATURE MEDICINE, 1999, 5 (10) :1143-1149

[10] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].

CHEN, C ;

OKAYAMA, H .

MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752

← 1 2 3 4 5 6 7 8 →